AIDS Vaccine Bike Trek

The annual AIDS Vaccine Bike Trek is a 445-mile, charity bike ride through 4 states in the mountains and countryside of New England. The ride raises critical funds for research at the Emory Vaccine Center and the UCLA AIDS Institute, two of the world's leading vaccine research centers working to find an HIV vaccine.

2009 AIDS Vaccine Bike Trek|

The Ride

The ride takes place the second week of August each year. Up to 100 cyclists and numerous volunteers complete the ride each year. Cyclists and Crew members camp nightly in Parks and Campgrounds along the route, with daily mileage ranging between 60 and 115 miles.

Ride List

Charity Treks, Inc has organized several AIDS Vaccine Bike Treks in North America:

  • Burlington to Portalnd AIDS Vaccine BikeTrek 2009 (August 11-15, 2009)
  • Burlington to Portland AIDS Vaccine BikeTrek 2008 (Raised $92,486)
  • Montreal to Portland AIDS Vaccine BikeTrek 2007 (Raised $124,075)
  • Montreal to Portland AIDS Vaccine BikeTrek 2006 (Raised $111,500)
  • Montreal to Boston AIDS Vaccine BikeTrek 2005 (Raised $100,645)
  • Montreal to Boston AIDS Vaccine BikeTrek 2004 (Raised $118,150)
  • Montreal to Boston AIDS Vaccine BikeTrek 2003 (Raised $81,357)
  • Montreal to Maine AIDS Vaccine BikeTrek 2002 (Raised $100,000)

History

Charity Treks was formed in 2002 by a group of cyclists who had paricipated in the 2001 Montreal to Maine AIDS Vaccine Bike Trek, one of the last AIDSRides produced by Pallotta Teamworks. The original event was organized by Palotta TeamWorks but was cancelled in 2002 due to funding issues. A group of riders continued to do the ride that year despite the lack of organizational structure.

The riders and volunteers were committed to the cause of raising the public awareness AbOUT AIDS, and felt compelled to not let this be a one-time event. As a result, a number or riders and volunteers gathered together to form a volunteer organization whose purpose is to forward the cause of AIDS awareness and raise funds for vital research in the development of a vaccine. 100% of funds raised are donated to the two charitable beneficiaries; Emory Vaccine Center and UCLA AIDS Institute

See also

  • Charitable organization
  • HIV vaccine